![Eugene Lin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eugene Lin
Technik-/Wissenschafts-/F&E-Leiter bei Vita Genomics, Inc.
Profil
Eugene Lin is currently working as Senior Director-Research & Development at Vita Genomics, Inc. and also as Adjunct Assistant Professor at China Medical University.
He holds a doctorate degree from the University of Washington.
Aktive Positionen von Eugene Lin
Unternehmen | Position | Beginn |
---|---|---|
Vita Genomics, Inc.
![]() Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 |
China Medical University | Corporate Officer/Principal | 12.08.2010 |
Ausbildung von Eugene Lin
University of Washington | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Vita Genomics, Inc.
![]() Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Health Services |